The STEP trials for semaglutide and the SURMOUNT trials for tirzepatide established injection as the delivery method with the strongest clinical backing
Independent, licensed providers on the Eden platform can help determine if a GLP-1 injection is appropriate based on a full medical evaluation
The smart expansion play is to broaden access to branded, FDA-approved options (injectable and oral GLP-1s), integrate with manufacturer direct channels like LillyDirect and NovoCare, and deepen the services that pure fulfillment can't match: prior authorization and denial-appeal support, employer-benefit syncing to find patients their lowest out-of-pocket cost, nutrition and coaching, and maintenance pathways
These include: Nausea the most frequently reported adverse effect, particularly during dose escalation Vomiting Diarrhoea Constipation Decreased appetite (which, whilst therapeutically intended, can occasionally be excessive) Abdominal discomfort or pain These effects are generally dose-dependent and tend to be most pronounced during the initial weeks of treatment or when the dose is increased
The company is offering same-day delivery in nearly 3,000 cities, with plans to expand to 4,500 locations by the end of 2026
